Skip to main content
Holiday Sale — Get 40% off Vantage for yourself or as a gift
Published loading...Updated

I like Rohto Pharma's partnership with a year-to-date high-value AI startup

Summary by Nikkei
The stock of Rotenberg Pharmaceuticals remains stable. On the 25th, it closed at 34,230 yen, an increase of 99 yen (3%) from the previous day, and updated the highest level this year. On the 24th, it announced a capital business partnership with AI startup Recursive (Tokyo, Shibuya) . The stock was bought based on expectations of business expansion through AI utilization. The closing price was 3,336 yen, an increase of 12 yen (0.4%). On the 14th…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

Lean Right

The stock of Rotenberg Pharmaceuticals remains stable. On the 25th, it closed at 34,230 yen, an increase of 99 yen (3%) from the previous day, and updated the highest level this year. On the 24th, it announced a capital business partnership with AI startup Recursive (Tokyo, Shibuya) . The stock was bought based on expectations of business expansion through AI utilization. The closing price was 3,336 yen, an increase of 12 yen (0.4%). On the 14th…

·Japan
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Nikkei broke the news in Japan on Tuesday, June 25, 2024.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal